Chad Gassert
About Chad Gassert
Chad Gassert is the Sr. Vice President of Corporate Development and Strategy at ANI Pharmaceuticals, having joined the company in November 2021 after serving as Co-Founder and CEO of Novitium Pharma.
Chad Gassert Corporate Development and Strategy
Chad Gassert is the Sr. Vice President of Corporate Development and Strategy at ANI Pharmaceuticals. He took on this role in November 2021 following ANI Pharmaceuticals' acquisition of Novitium Pharma, a company he co-founded and led as CEO. At ANI Pharmaceuticals, Chad focuses on corporate strategy and growth initiatives.
Chad Gassert Background and Career
Chad Gassert has a substantial background in the pharmaceutical industry. Prior to joining ANI Pharmaceuticals, he co-founded Novitium Pharma and served as its CEO. His leadership at Novitium involved developing a fully integrated generic pharmaceutical company that emphasizes research and development, manufacturing, and distribution.
Chad Gassert Expertise and Positions Held
Chad Gassert's expertise in pharmaceuticals is well-documented through his various roles in the industry. Between 2005 and 2016, he worked at Par Pharmaceuticals where he held leadership roles such as Senior Vice President of Business Development. In this position, he managed corporate and business development activities including mergers and acquisitions, partnerships, licensing, and strategic sourcing.
Chad Gassert Educational Background
Chad Gassert holds a Bachelor of Science degree from the University of Delaware. His education provided a foundation for his roles as a formulation and technical services scientist at Sandoz and Wyeth before advancing to senior management positions in the pharmaceutical industry.